Markers of progenitor cell recruitment and differentiation rise early during ischemia and continue during resuscitation in a porcine acute ischemia model

Journal of Interferon and Cytokine Research

Volumn 31, Issue 6, 2011, Pages 509-513

  Shah, Atman P ^a   Youngquist, Scott T ^b   McClung, Christian D ^c   Tzvetkova, Ekaterina ^d   Hanif, Mohammed A ^d   Rosborough, John P ^d   Niemann, James T ^d,e  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d HARBOR UCLA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; THYMOSIN BETA4; VASCULOTROPIN;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BALLOON OCCLUSION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART ARREST; HEART VENTRICLE FIBRILLATION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESUSCITATION; STEM CELL; VENOUS BLOOD;

ANIMALS; BALLOON OCCLUSION; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL MOVEMENT; DISEASE MODELS, ANIMAL; HEART ARREST; HUMANS; MATRIX METALLOPROTEINASE 9; MYOCARDIAL ISCHEMIA; REGENERATIVE MEDICINE; RESUSCITATION; STEM CELL TRANSPLANTATION; SWINE; THYMOSIN; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VENTRICULAR REMODELING;

ANIMALIA; SUS; SUS SCROFA DOMESTICA;

EID: 79958187910     PISSN: 10799907     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.2010.0133     Document Type: Article

References (33)

1. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G. 2003. Plasma concentrations and genetic variations of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation 107:1579-1585 (Pubitemid 36397324)
2. Bock-Marquette I, Saxena A, White MD, Dimaio JM, Srivastava D. 2004. Thymosin beta4 activates integrin linked kinase and promotes cardiac cell migration, survival and cardiac repair. Nature 432(7016):466-472 (Pubitemid 39576522)
3. Bock-Marquette I, Shrivastava S, Pipes GC, Thatcher JE, Blys-tone A, Shelton JM, Galindo CL, Melegh B, Srivastava D, Olson EN, Di Maio JM. 2009. Thymosin beta4 mediated PKC activation is essential to initiate the embryonic coronary developmental program and epicardial progenitor cell activation in adult mice in vivo. J Mol Cell Cardiol 46(5):728-738.
4. Chavakis E, Koyanagi M, Dimmeler S. 2010. Enhancing the outcome of cell therapy for cardiac repair: Progress from bench to bedside and back. Circulation 121:325-335.
5. Crockford D. 2007. Development of thymosin beta4 for treatment of patients with ischemic heart disease. Ann NY Acad Sci 1112:385-395. (Pubitemid 47598686)
6. Crockford D, Turjman N, Allan C, Angel J. 2010. Thymosin beta4: Structure, function, and biological properties supporting current and future clinical applications. Ann NY Acad Sci 1194:179-189.
7. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE. 2000. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collage accumulation after experimental myocardial infarction. J Clin Invest 106:55-62. (Pubitemid 30437240)
8. Eskens FA, Verweij J. 2006. The clinical toxicity profile of vascular endothelial growth factor (VEGF) and vascular endo-thelial growth factor receptor (VEGFR) targeting angiogenesis inhibitors: A review. Eur J Cancer 42(18):3127-3139. (Pubitemid 44869016)
9. Fang L, Du XJ, Gao XM, Dart A. 2009. Acute myocardial infarction enhances production of MMP-9 by peripheral blood mononuclear cells. Heart Lung Circ 18S:S299-S318.
10. Gargioli C, Coletta M, De Grandis F, Cannata SM, Cossu G. 2008. PIGF, MMP-9 expressing cells restore microcirculation and efficacy of cell therapy in aged dystrophic muscle. Nat Med 14:973-978.
11. Gonzalez GE, Rabald S, Briest W, Gelpi RJ, Seropian I, Zimmer HG, Deten A. 2009. Ribose treatment reduced the infarct size and improved heart function after myocardial infarction in rats. Cell Physiol Biochem 24:211-218.
12. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Yung S, Chimenti S, Landsman L, Abramovitch R, Keshet E. 2006. VEGF-induced adult neovascularization: Recruitment, retention, and role of accessory cells. Cell 124:175-189. (Pubitemid 43069318)
13. Guedez L, Stetler-Stevenson WG, Wolff L, Wang J, Fukushima P, Mansoor A, Stetler-Stevenson M. 1998. In vitro suppression of programmed cell death of B cells by tissue inhibitor of me-talloproteinases-1. J Clin Invest 102:2002-2010. (Pubitemid 29001847)
14. Hinkel R, Bock-Marquette I, Hazopoulos AK, Kupatt C. 2010. Thymosin beta4: A key factor for protective effects of eEPCs in acute and chronic ischemia. Ann NY Acad Sci 1194:105-111.
15. Huang CX, Yuan MJ, Huang H, Wu G, Liu Y, Yu SB, Li HT, Wang T. 2009. Ghrelin inhibits post-infarct myocardial remodeling and improves cardiac function through anti-inflammation effect. Peptides 30(12):2286-2291.
16. Kelly D, Cockerill G, Ng LL, Thompson M, Khan S, Samani NJ, Squire IB. 2007. Plasma matrix metalloproteinase-9 and left ventricular remodeling after acute myocardial infarction in man: A prospective cohort study. Eur Heart J 3:1-8.
17. Lahteenvuo JE, Lahteenvuo MK, Kivela A, Rosenlew C, Falkevall A, Klar J, Heikura T, Rissanen TT, Vahakangas E, Korpisalo P, Enholm B, Carmeliet P, Alitalo K, Eriksson U, Yla-Hertuala S. 2009. Vascular endothelial growth factor-b induces myocar dium specific angiogenesis and arteriogenesis via vascular endothelial growth factor receptor-1 and neuropilin receptor 1 dependent mechanisms. Circulation 119:845-856.
18. Lee SH, Wolf PL, Escudero R, Deutsch R, Jamieson SW, This-tlethwaite PA. 2000. Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med 342:626-633. (Pubitemid 30118415)
19. Li Z, Guo J, Chang Q, Zhang A. 2009. Paracrine role for mes-enchymal stem cells in acute myocardial infarction. Biol Pharm Bull 32(8):1343-1346.
20. Lim SY, Kim YS, Ahn Y, Jeong MH, Hong MH, Joo SY, Nam KI, Cho JG, Kang PM, Park JC. 2006. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 70(3):530-542. (Pubitemid 43732376)
21. Lipinski MJ, Biondi-Zoccai GG, Abbate A, Khianey R, Sheiban I, Bartunek J, Vanderheyden M, Kim HS, Kang HJ, Strauer BE, Vetrovec GW. 2007. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: A collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50:1761-1767. (Pubitemid 47600592)
22. Neto-Neves EM, Dias-Junior CA, Rizzi E, Castro MM, Sonego F, Gerlach RF, Tanus-Santus JE. 2010. Metalloproteinase inhibition protects against cardiomyocyte injury during experimental acute pulmonary thromboembolism. Crit Car Med 39:349-356.
23. Rossdeutch A, Smart N, Riley PR. 2008. Thymosin beta4 and Ac-SDKP: Tools to mend a broken heart. J Mol Med 86(1):29-35.
24. Ruff D, Crockford D, Girardi G, Zhang Y. 2010. A randomized, placebo-controlled, single and multiple dose study of intravenous thymosin beta4 in healthy volunteers. Ann NY Acad Sci 1194:223-229.
25. Silvestre JS, Tmarat R, Ebrahimian TG, Le-Roux A, Clergue M, Emmanuel F, Duriez m, Schwartz B, Branellee D, Levy BL. 2003. Vascular endothelial growth factor-B promotes in vivo angiogenesis. Circ Res 93:114-123. (Pubitemid 36919698)
26. Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, Chien KR, Riley PR. 2007. Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445(7124):77-82
27. Sosne G, Qiu P, Goldstein AL, Wheater M. 2010. Biological activities of thymosin beta 4 defined by active sites in short peptide sequences. FASEB 24:1-8.
28. Squire IB, Evans J, Ng LL, Loftus IM, Thompson MM. 2004. Plasma MMP-9 and MMP-2 following acute myocardial infarction in Man: Correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Fail 10:328-333. (Pubitemid 39092685)
29. Srivastava D, Saxena A, Dimaio JM, Bock-Marquette I. 2007. Thymosin beta4 is cardioprotective after myocardial infarction. Ann NY Acad Sci 1112:161-170. (Pubitemid 47598683)
30. Tang YL, Zhao Q, Qin Z, Shen L, Cheng L, Ge J, Phillips MA. 2005. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 80(1):229-237. (Pubitemid 40840214)
31. Varneaeva E, Naderzhda A, Hannappel E, Sjogren MH, Rojkind M. 2007. Thymosin beta4 upregulates the expression of he-patocyte growth factor and downregulates the expression of PDGF-beta receptor in hepatic stellate cells. Ann NY Acad Sci 1112:154-160. (Pubitemid 47598673)
32. Walter DH, Haendeler J, Reinhold J, Rochwalsky U, Seeger F, Honold J, Hoffmann J, Urbich C, Lehmann R, Arenzana-Seisdesdos F, Aicher A, Heeschen C, Fichtlscherer S, Zeiher AM, Dimmeler S. 2005. Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Circ Res 97:1142-1151.
33. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. 1987. Left ventricular end systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76:44-51. (Pubitemid 17093191)